Riskpilot← Back to searchSign inGet full accessMecum AB
ABActiveOrg 5566437561Hagalundsvägen 39 BGeneral medical practice activities · NACE 8621Est. 20030 employees
Revenue 2025
SEK 0
EBITDA margin
—
-37% vs 2024
Equity ratio
76.9%
Financial strength
Net profit 2025
SEK 954K
-18% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -41K | -37% |
| Net profit | SEK 954K | -18% |
| Total assets | SEK 4,7M | +11% |
| Equity | SEK 3,6M | -15% |
| Employees | 0 | — |
Legal name
Mecum AB
Org number
5566437561
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 maj 2003
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Wesslén Wiberg, Karin Ulrika C Wiberg, Lars Johan Magnus Firman tecknas i förening av Wiberg, Anna Rebecca Beatrice Wiberg, Carl Hampus Jonathan
Company purpose
Aktiebolaget ska bedriva värdepapperförvaltning samt därmed förenlig verksamhet.
Address
Hagalundsvägen 39 B
Email
ulrica.winberg@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −28 | −14 | −53 | −30 | −41 |
| Depreciation & amort. | −4 | −0 | −0 | −0 | −0 |
| EBIT | −32 | −14 | −53 | −30 | −41 |
| Net financials | −86 | −6 | 212 | 1 000 | 914 |
| Profit before tax | −76 | −17 | 348 | 1 164 | 954 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −76 | −17 | 348 | 1 164 | 954 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 837 | 3 420 | 3 785 | 4 227 | 4 682 |
| Equity | 2 716 | 2 699 | 3 047 | 4 211 | 3 600 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 121 | 721 | 737 | 15 | 1 082 |
| Total debt | 1 121 | 721 | 737 | 15 | 1 082 |
EBITDA margin
-4100000.0%
This company
15.8%
Market median
-25949467% vs market
20212025
Equity ratio
76.9%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
26.5%
This company
18.4%
Market median
+44% vs market
20212025
Net profit margin
95400000.0%
This company
8.1%
Market median
+1177777678% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mecum AB 
Tandläkarna Wiberg AktiebolagBoard members of Mecum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Jörgen Askengren | Audit | 0 companies |
| Lars Johan Magnus Wiberg | Chairman | 0 companies |
| Carl Hampus Jonathan Wiberg | Board of Directors | 0 companies |
| Karin Ulrika C Wesslén Wiberg | Board of Directors | 0 companies |
| Anna Rebecca Beatrice Wiberg | Board of Directors | 0 companies |